This inventor holds 3 USPTO granted patents. Top assignee: The Upjohn Co.. Active years: 1981-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1982
Title: Kevin E Brooks: Innovator in Microbiological Processes
Introduction
Kevin E Brooks is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of microbiology, particularly in the transformation of steroids. With a total of 3 patents to his name, Brooks has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Brooks has developed a Mycobacterium fortuitum mutant. This mutant is utilized in a novel microbiological process to selectively transform steroids that have 17-alkyl side chains ranging from 2 to 10 carbon atoms. The process yields androst-4-ene-3,17-dione (AD) as the primary transformed product. AD serves as a valuable intermediate for the production of useful steroids.
Career Highlights
Kevin E Brooks is currently associated with The Upjohn Company, where he continues to innovate and contribute to advancements in microbiological processes. His work has implications for the pharmaceutical industry, particularly in the development of steroid-based medications.
Collaborations
One of his notable coworkers is Merle G Wovcha, with whom he has likely collaborated on various projects within the company.
Conclusion
Kevin E Brooks is a distinguished inventor whose work in microbiology has led to significant advancements in steroid transformation processes. His contributions continue to impact the field and the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile